12 results on '"Unger, Kristian"'
Search Results
2. Utility of gene expression studies in relation to radiation exposure and clinical outcomes: thyroid cancer in the Ukrainian-American cohort and late health effects in a MAYAK worker cohort.
- Author
-
Abend, Michael, Pfeiffer, Ruth M., Port, Matthias, Hatch, Maureen, Bogdanova, Tetyana, Tronko, Mykola D., Mabuchi, Kiyohiko, Azizova, Tamara, Unger, Kristian, Braselmann, Herbert, Ostheim, Patrick, and Brenner, Alina V.
- Subjects
RADIATION exposure ,THYROID cancer ,GENE expression ,RADIATION protection ,GAMMA rays - Abstract
We herein report on changes in gene expression after radiation exposure to iodine-131 from the Chernobyl accident in the Ukrainian-American thyroid cohort and to external gamma ray or internal plutonium exposure in the Mayak Production Association radiation workers. Taking advantage of access to tissue samples from the thyroid cancer cases in the Ukrainian-American cohort, our group tried to identify candidate genes to discriminate spontaneously occurring thyroid cancers from thyroid cancers caused by radiation exposure. We also examined gene expression changes in normal and cancerous thyroid tissue in relation to iodine-131 dose separately. Gene expression changes in the peripheral blood of radiation exposed Mayak workers were examined to elucidate the dose-to-gene and gene-to-health (e.g. cardiovascular disease) relationships. Results of both projects are discussed under the aspect of dose-response relationships (dose-to-gene) and clinical outcome relationships (gene-to-effect) in light of how mechanistic data can be translated into actionable knowledge for radiation protection or clinical purposes. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
3. Transcriptome network of the papillary thyroid carcinoma radiation marker CLIP2.
- Author
-
Selmansberger, Martin, Michna, Agata, Braselmann, Herbert, Höfig, Ines, Schorpp, Kenji, Weber, Peter, Anastasov, Natasa, Zitzelsberger, Horst, Hess, Julia, and Unger, Kristian
- Subjects
PAPILLARY carcinoma ,THYROID cancer ,CANCER cell culture ,PEPTIDYLPROLYL isomerase ,RADIATION - Abstract
Background: We present a functional gene association network of the CLIP2 gene, generated by de-novo reconstruction from transcriptomic microarray data. CLIP2 was previously identified as a potential marker for radiation induced papillary thyroid carcinoma (PTC) of young patients in the aftermath of the Chernobyl reactor accident. Considering the rising thyroid cancer incidence rates in western societies, potentially related to medical radiation exposure, the functional characterization of CLIP2 is of relevance and contributes to the knowledge about radiation-induced thyroid malignancies.Methods: We generated a transcriptomic mRNA expression data set from a CLIP2-perturbed thyroid cancer cell line (TPC-1) with induced CLIP2 mRNA overexpression and siRNA knockdown, respectively, followed by gene-association network reconstruction using the partial correlation-based approach GeneNet. Furthermore, we investigated different approaches for prioritizing differentially expressed genes for network reconstruction and compared the resulting networks with existing functional interaction networks from the Reactome, Biogrid and STRING databases. The derived CLIP2 interaction partners were validated on transcript and protein level.Results: The best reconstructed network with regard to selection parameters contained a set of 20 genes in the 1st neighborhood of CLIP2 and suggests involvement of CLIP2 in the biological processes DNA repair/maintenance, chromosomal instability, promotion of proliferation and metastasis. Peptidylprolyl Isomerase Like 3 (PPIL3), previously identified as a potential direct interaction partner of CLIP2, was confirmed in this study by co-expression at the transcript and protein level.Conclusion: In our study we present an optimized preselection approach for genes subjected to gene-association network reconstruction, which was applied to CLIP2 perturbation transcriptome data of a thyroid cancer cell culture model. Our data support the potential carcinogenic role of CLIP2 overexpression in radiation-induced PTC and further suggest potential interaction partners of the gene. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
4. Integration of a radiation biomarker into modeling of thyroid carcinogenesis and post-Chernobyl risk assessment.
- Author
-
Kaiser, Jan Christian, Meckbach, Reinhard, Eidemüller, Markus, Selmansberger, Martin, Unger, Kristian, Shpak, Viktor, Blettner, Maria, Zitzelsberger, Horst, and Jacob, Peter
- Subjects
RADIATION exposure ,THYROID cancer ,CHERNOBYL Nuclear Accident, Chornobyl, Ukraine, 1986 ,HEALTH risk assessment ,EPIDEMIOLOGICAL research ,CARCINOGENESIS - Abstract
Strong evidence for the statistical association between radiation exposure and disease has been produced for thyroid cancer by epidemiological studies after the Chernobyl accident. However, limitations of the epidemiological approach in order to explore health risks especially at low doses of radiation appear obvious. Statistical fluctuations due to small case numbers dominate the uncertainty of risk estimates. Molecular radiation markers have been searched extensively to separate radiation-induced cancer cases from sporadic cases. The overexpression of the CLIP2 gene is the most promising of these markers. It was found in the majority of papillary thyroid cancers (PTCs) from young patients included in the Chernobyl tissue bank. Motivated by the CLIP2 findings we propose a mechanistic model which describes PTC development as a sequence of rate-limiting events in two distinct paths of CLIP2-associated and multistage carcinogenesis. It integrates molecular measurements of the dichotomous CLIP2 marker from 141 patients into the epidemiological risk analysis for about 13 000 subjects from the Ukrainian-American cohort which were exposed below age 19 years and were put under enhanced medical surveillance since 1998. For the first time, a radiation risk has been estimated solely from marker measurements. Cross checking with epidemiological estimates and model validation suggests that CLIP2 is a marker of high precision. CLIP2 leaves an imprint in the epidemiological incidence data which is typical for a driver gene. With the mechanistic model, we explore the impact of radiation on the molecular landscape of PTC. The model constitutes a unique interface between molecular biology and radiation epidemiology. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
5. Gene signature of the post-Chernobyl papillary thyroid cancer.
- Author
-
Handkiewicz-Junak, Daria, Swierniak, Michal, Rusinek, Dagmara, Oczko-Wojciechowska, Małgorzata, Dom, Genevieve, Maenhaut, Carine, Unger, Kristian, Detours, Vincent, Bogdanova, Tetiana, Thomas, Geraldine, Likhtarov, Ilya, Jaksik, Roman, Kowalska, Malgorzata, Chmielik, Ewa, Jarzab, Michal, Swierniak, Andrzej, and Jarzab, Barbara
- Subjects
THYROID cancer ,MOLECULAR biology ,RADIATION exposure ,GENE expression ,MESSENGER RNA ,CHERNOBYL Nuclear Accident, Chornobyl, Ukraine, 1986 - Abstract
Purpose: Following the nuclear accidents in Chernobyl and later in Fukushima, the nuclear community has been faced with important issues concerning how to search for and diagnose biological consequences of low-dose internal radiation contamination. Although after the Chernobyl accident an increase in childhood papillary thyroid cancer (PTC) was observed, it is still not clear whether the molecular biology of PTCs associated with low-dose radiation exposure differs from that of sporadic PTC. Methods: We investigated tissue samples from 65 children/young adults with PTC using DNA microarray (Affymetrix, Human Genome U133 2.0 Plus) with the aim of identifying molecular differences between radiation-induced (exposed to Chernobyl radiation, ECR) and sporadic PTC. All participants were resident in the same region so that confounding factors related to genetics or environment were minimized. Results: There were small but significant differences in the gene expression profiles between ECR and non-ECR PTC (global test, p < 0.01), with 300 differently expressed probe sets ( p < 0.001) corresponding to 239 genes. Multifactorial analysis of variance showed that besides radiation exposure history, the BRAF mutation exhibited independent effects on the PTC expression profile; the histological subset and patient age at diagnosis had negligible effects. Ten genes ( PPME1, HDAC11, SOCS7, CIC, THRA, ERBB2, PPP1R9A, HDGF, RAD51AP1, and CDK1) from the 19 investigated with quantitative RT-PCR were confirmed as being associated with radiation exposure in an independent, validation set of samples. Conclusion: Significant, but subtle, differences in gene expression in the post-Chernobyl PTC are associated with previous low-dose radiation exposure. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
6. Genomic copy number analysis of Chernobyl papillary thyroid carcinoma in the Ukrainian-American Cohort.
- Author
-
Selmansberger, Martin, Braselmann, Herbert, Hess, Julia, Bogdanova, Tetiana, Abend, Michael, Tronko, Mykola, Brenner, Alina, Zitzelsberger, Horst, and Unger, Kristian
- Subjects
DNA copy number variations ,THYROID cancer ,PAPILLARY carcinoma ,AMERICANS ,COHORT analysis ,COMPARATIVE genomic hybridization ,DATA analysis ,MULTIVARIATE analysis ,DISEASES - Abstract
One of the major consequences of the 1986 Chernobyl reactor accident was a dramatic increase in papillary thyroid carcinoma (PTC) incidence, predominantly in patients exposed to the radioiodine fallout at young age. The present study is the first on genomic copy number alterations (CNAs) of PTCs of the Ukrainian-American cohort (UkrAm) generated by array comparative genomic hybridization (aCGH). Unsupervised hierarchical clustering of CNA profiles revealed a significant enrichment of a subgroup of patients with female gender, long latency (>17 years) and negative lymph node status. Further, we identified single CNAs that were significantly associated with latency, gender, radiation dose and BRAF V600E mutation status. Multivariate analysis revealed no interactions but additive effects of parameters gender, latency and dose on CNAs. The previously identified radiation-associated gain of the chromosomal bands 7q11.22-11.23 was present in 29% of cases. Moreover, comparison of our radiation-associated PTC data set with the TCGA data set on sporadic PTCs revealed altered copy numbers of the tumor driver genes NF2 and CHEK2. Further, we integrated the CNA data with transcriptomic data that were available on a subset of the herein analyzed cohort and did not find statistically significant associations between the two molecular layers. However, applying hierarchical clustering on a 'BRAF-like/RAS-like' transcriptome signature split the cases into four groups, one of which containing all BRAF-positive cases validating the signature in an independent data set. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
7. Dose-dependent expression of CLIP2 in post-Chernobyl papillary thyroid carcinomas.
- Author
-
Selmansberger, Martin, Kaiser, Jan Christian, Hess, Julia, Güthlin, Denise, Likhtarev, I., Shpak, Victor, Tronko, Mykola, Brenner, Alina, Abend, Michael, Blettner, Maria, Unger, Kristian, Jacob, Peter, and Zitzelsberger, Horst
- Subjects
GENE expression ,PAPILLARY carcinoma ,THYROID cancer ,CHERNOBYL Nuclear Accident, Chornobyl, Ukraine, 1986 ,MESSENGER RNA - Abstract
A previous study on papillary thyroid carcinomas (PTC) in young patients who were exposed to 131iodine from the Chernobyl fallout revealed an exclusive gain of chromosomal band 7q11.23 in exposed cases compared to an age-matched control cohort. CLIP2, a gene located within band 7q11.23 was shown to be differentially expressed between exposed and nonexposed cases at messenger RNA and protein level. Therefore, a standardized procedure for CLIP2 typing of PTCs has been developed in a follow-up study. Here we used CLIP2 typing data on 117 post-Chernobyl PTCs from two cohorts of exposed patients with individual dose estimates and 24 non-exposed controls to investigate a possible quantitative dose-response relationship of the CLIP2 marker. The 'Genrisk-T' cohort consisted of 45 PTCs and the 'UkrAm' cohort of 72 PTCs. Both cohorts differed in mean dose (0.59 Gy Genrisk-T, 1.2 Gy UkrAm) and mean age at exposure (AaE) (2 years Genrisk-T, 8 years UkrAm), whilst the median latency (16 years Genrisk-T, 18 years UkrAm) was comparable. We analyzed the association between the binary CLIP2 typing and continuous thyroid dose with logistic regression. A clear positive dose-response relationship was found for young PTC cases [age at operation (AaO) < 20 years, AaE < 5 years]. In the elder age group a higher proportion of sporadic tumors is assumed due to a negligible dose response, suggesting different molecular mechanisms in sporadic and radiation-induced cases. This is further supported by the association of elder patients (AaO > 20 years) with positivity for BRAF V600E mutation. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
8. Anterior gradient protein 2 promotes survival, migration and invasion of papillary thyroid carcinoma cells.
- Author
-
Di Maro, Gennaro, Salerno, Paolo, Unger, Kristian, Orlandella, Francesca Maria, Monaco, Mario, Chiappetta, Gennaro, Thomas, Gerry, Oczko-Wojciechowska, Malgorzata, Masullo, Mariorosario, Jarzab, Barbara, Santoro, Massimo, and Salvatore, Giuliana
- Subjects
CANCER cell enzymes ,CANCER cells ,THYROID cancer ,ENDOPLASMIC reticulum ,POLYMERASE chain reaction ,GENE therapy ,GENETICS ,PHYSIOLOGY - Abstract
Background Through a transcriptome microarray analysis, we have isolated Anterior gradient protein 2 (AGR2) as a gene up-regulated in papillary thyroid carcinoma (PTC). AGR2 is a disulfide isomerase over-expressed in several human carcinomas and recently linked to endoplasmic reticulum (ER) stress. Here, we analyzed the expression of AGR2 in PTC and its functional role. Methods Expression of AGR2 was studied by immunohistochemistry and real time PCR in normal thyroids and in PTC samples. The function of AGR2 was studied by knockdown in PTC cells and by ectopic expression in non-transformed thyroid cells. The role of AGR2 in the ER stress was analyzed upon treatment of cells, expressing or not AGR2, with Bortezomib and analyzing by Western blot the expression levels of GADD153. Results PTC over-expressed AGR2 at mRNA and protein levels. Knockdown of AGR2 in PTC cells induced apoptosis and decreased migration and invasion. Ectopic expression of AGR2 in non-transformed human thyroid cells increased migration and invasion and protected cells from ER stress induced by Bortezomib. Conclusions AGR2 is a novel marker of PTC and plays a role in thyroid cancer cell survival, migration, invasion and protection from ER stress. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
9. RET/PTC Rearrangement Occurring in Primary Peritoneal Carcinoma.
- Author
-
Flavin, Richard, Jackl, Gerhard, Finn, Stephen, Smyth, Paul, Ring, Martina, O'Regan, Esther, Cahill, Susanne, Unger, Kristian, Denning, Karen, Jinghuan Li, Aherne, Sinead, Tallini, Giovanni, Gaffney, Eoin, O'Leary, J. J., Zitzelsberger, Horst, and Sheils, Orla
- Subjects
PERITONEAL cancer ,THYROID cancer ,GENETIC mutation ,REVERSE transcriptase ,POLYMERASE chain reaction ,IMMUNOHISTOCHEMISTRY ,FLUORESCENCE in situ hybridization - Abstract
RET/PTC rearrangements are initiating events in the development of a significant proportion of papillary thyroid carcinomas. Activated RET/PTC mutations are thought to be restricted to thyroid disease, but this study proposes that these events may also occur in nonthyroid tumors. A total of 57 nonthyroid papillary tumors were examined for RET/PTC rearrangements using interphase fluorescence in situ hybridization, Taqman reverse transcriptase polymerase chain reaction, and immunohistochemistry. Taqman single nucleotide polymorphism detection was used to analyze for expression of mutated BRAF T1799A. In all, 20% (3/15) of primary peritoneal carcinoma had detectable RET/PTC1 rearrangements by all 3 methodologies. A further case of similar histotype had an alternate RET/PTC rearrangement. No RET/PTC1 rearrangements were detected in the remaining tumor cohort. All 57 tumors were homozygous for wild-type BRAF. The results indicate that RET/PTC rearrangements occur in a small subset of nonthyroid papillary tumors. These rearrangements may not be directly implicated in tumor growth; rather representing "passenger" mutations reflecting RET instability in secondary tumor subclones. [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
10. Chromosomal aberrations in thyroid follicular-cell neoplasia: in the search of novel oncogenes and tumour suppressor genes
- Author
-
Zitzelsberger, Horst, Thomas, Gerry, and Unger, Kristian
- Subjects
- *
CHROMOSOME abnormalities , *THYROID cancer , *B cell lymphoma , *ONCOGENES , *MOLECULAR biology , *GENE expression , *GENETIC markers , *TARGETED drug delivery , *CHROMOSOMES - Abstract
Abstract: Thyroid cancer derived from the follicular cell is characterised by specific gene alterations that are closely linked to the various pathological types comprising papillary, follicular and anaplastic thyroid cancer. However, the correlation between molecular biology and pathology is not absolute, since about 30% of cases do not harbour the typical gene alterations. This situation, coupled with the demonstration of genetic heterogeneity in thyroid cancer, is a strong motivation for the search of novel gene alterations. Chromosomal aberrations are a good starting point to initiate this search and therefore the current knowledge on chromosomal alterations in thyroid follicular-cell neoplasia is reviewed in this article. An overview on molecular cytogenetic approaches for this strategy is also provided. The identification of novel genetic markers in thyroid cancer will be further improved by integrative approaches combining data from genomic and expression analyses with clinical data. This approach is powerful to identify genetic markers as well as new therapeutic targets in follicular-cell thyroid cancer. [Copyright &y& Elsevier]
- Published
- 2010
- Full Text
- View/download PDF
11. Molecular rearrangements in papillary thyroid carcinomas
- Author
-
Zitzelsberger, Horst, Bauer, Verena, Thomas, Gerry, and Unger, Kristian
- Subjects
- *
GENE rearrangement , *THYROID cancer , *EPITHELIAL tumors , *CHROMOSOMAL rearrangement , *ONCOGENES , *DNA , *GENE fusion , *MOLECULAR genetics - Abstract
Abstract: Papillary thyroid cancer is unusual among epithelial malignancies in that it is associated with a number of chromosomal rearrangements. The most common of these is the Ret oncogene, normally silent in the follicular cell, but which has been shown to be rearranged to the promoter region of a variety of different genes, all of which are constituently expressed in the thyroid follicular cell. It has been suggested that chromosomes in the thyroid cell are arranged within the nucleus in such a way as to predispose the cell to inappropriate fusion in the advent of DNA double-strand breakage. The presence of tumour specific fusion genes, and their transcribed proteins, presents a possible therapeutic target for thyroid cancer, but the relative contribution of the gene rearrangement in the growth and development of the tumour will need careful evaluation before clinical studies could take place. [Copyright &y& Elsevier]
- Published
- 2010
- Full Text
- View/download PDF
12. Anterior gradient protein 2 promotes survival, migration and invasion of papillary thyroid carcinoma cells
- Author
-
Gerry Thomas, Kristian Unger, Malgorzata Oczko-Wojciechowska, Paolo Salerno, Gennaro Di Maro, Giuliana Salvatore, Mariorosario Masullo, Mario Monaco, Francesca Maria Orlandella, Massimo Santoro, Barbara Jarzab, Gennaro Chiappetta, DI MARO, Gennaro, Salerno, Paolo, Unger, Kristian, Orlandella, FRANCESCA MARIA, Monaco, Mario, Chiappetta, Gennaro, Thomas, Gerry, Oczko Wojciechowska, Malgorzata, Masullo, Mariorosario, Jarzab, Barbara, Santoro, Massimo, and Salvatore, Giuliana
- Subjects
Pathology ,Cancer Research ,HOMEOSTASIS ,Boronic Acid ,endocrine system diseases ,Survival ,Apoptosis ,Transcriptome ,Bortezomib ,Mucoproteins ,ENDOPLASMIC-RETICULUM STRESS ,Cell Movement ,DISULFIDE-ISOMERASE FAMILY ,Thyroid cancer ,Thyroid Neoplasm ,GENE-EXPRESSION ,Oncogene Proteins ,Gene knockdown ,PROLIFERATION ,Endoplasmic Reticulum Stress ,Boronic Acids ,Up-Regulation ,Cell Transformation, Neoplastic ,Thyroid Cancer, Papillary ,Gene Knockdown Techniques ,Pyrazines ,Molecular Medicine ,Life Sciences & Biomedicine ,Oxidation-Reduction ,Pyrazine ,Human ,AGR2 ,medicine.medical_specialty ,Biochemistry & Molecular Biology ,Cell Survival ,Protein Disulfide-Isomerases ,Biology ,CLASSIFICATION ,MECHANISMS ,Thyroid carcinoma ,LUNG-CANCER ,Cell Line, Tumor ,medicine ,Humans ,Migration and invasion ,Neoplasm Invasiveness ,Thyroid Neoplasms ,Endoplasmic Reticulum Stre ,PDI FAMILY ,Protein Disulfide-Isomerase ,Cell Proliferation ,Neoplasm Invasivene ,Science & Technology ,Endoplasmic reticulum ,Protein ,Research ,Carcinoma ,Apoptosi ,Proteins ,medicine.disease ,ONCOLOGY ,Carcinoma, Papillary ,Endoplasmic reticulum stress ,Gene Knockdown Technique ,Unfolded protein response ,Cancer research ,Ectopic expression - Abstract
Background Through a transcriptome microarray analysis, we have isolated Anterior gradient protein 2 (AGR2) as a gene up-regulated in papillary thyroid carcinoma (PTC). AGR2 is a disulfide isomerase over-expressed in several human carcinomas and recently linked to endoplasmic reticulum (ER) stress. Here, we analyzed the expression of AGR2 in PTC and its functional role. Methods Expression of AGR2 was studied by immunohistochemistry and real time PCR in normal thyroids and in PTC samples. The function of AGR2 was studied by knockdown in PTC cells and by ectopic expression in non-transformed thyroid cells. The role of AGR2 in the ER stress was analyzed upon treatment of cells, expressing or not AGR2, with Bortezomib and analyzing by Western blot the expression levels of GADD153. Results PTC over-expressed AGR2 at mRNA and protein levels. Knockdown of AGR2 in PTC cells induced apoptosis and decreased migration and invasion. Ectopic expression of AGR2 in non-transformed human thyroid cells increased migration and invasion and protected cells from ER stress induced by Bortezomib. Conclusions AGR2 is a novel marker of PTC and plays a role in thyroid cancer cell survival, migration, invasion and protection from ER stress.
- Published
- 2014
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.